Physical Activity Among Adolescent Cancer Survivors: The PACCS Study.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 09 2023
Historique:
accepted: 22 06 2023
medline: 4 9 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

Physical activity (PA) may modify risks of late effects after cancer. We aimed to examine levels of PA and sedentary time (ST) in a large, international sample of adolescent childhood cancer survivors in relation to sociodemographic and cancer-related factors and compare levels of PA and ST to reference cohorts. Survivors from any cancer diagnosis who had completed cancer treatment ≥1 year ago, aged 9 to 16 years, were eligible for the multicenter Physical Activity in Childhood Cancer Survivors study. PA and ST were measured by ActiGraph GT3X+ accelerometers. We performed linear regression analyses to assess factors associated with moderate-to-vigorous PA (MVPA) and ST, and compared marginal means of total PA, MVPA, and ST in 432 survivors to sex- and age-stratified references (2-year intervals) using immediate t-tests for aggregated data. Among survivors, 34% fulfilled the World Health Organization's PA recommendation of ≥60 min of daily MVPA on average and their ST was 8.7 hours per day. Being female, older, overweight, a survivor of central nervous system tumor, or having experienced relapse were associated with lower MVPA and/or higher ST. Generally, male survivors spent less time in MVPA compared with references, whereas female survivors had similar levels. Both male and female survivors had higher ST than references in nearly all age groups. The low PA and high ST in this large sample of adolescent childhood cancer survivors is worrisome. Combined, our results call for targeted interventions addressing both PA and ST in follow-up care after childhood cancer.

Identifiants

pubmed: 37646086
pii: 193791
doi: 10.1542/peds.2023-061778
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Auteurs

May Grydeland (M)

Departments of Physical Performance.

Mari Bratteteig (M)

Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway.

Corina S Rueegg (CS)

Oslo Centre for Biostatistics and Epidemiology.

Hanne C Lie (HC)

Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine.

Lene Thorsen (L)

National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Division of Cancer Medicine.
Division of Cancer Medicine, Department of Clinical Service.

Elna H Larsen (EH)

Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine.

Sabine Brügmann-Pieper (S)

Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Ingrid K Torsvik (IK)

Department of Pediatrics and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway.

Miriam Götte (M)

West German Cancer Center, University Hospital Essen, Essen, Germany.

Päivi M Lähteenmäki (PM)

Department of Pediatric and Adolescent Hematology and Oncology, Turku University Hospital, FICAN-West, University of Turku, Turku, Finland.

Susi Kriemler (S)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Martin K Fridh (MK)

Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Sigmund A Anderssen (SA)

Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway.

Ellen Ruud (E)

Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH